KRRO
Korro Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.13
+4.39%Margins
Gross margin
72.8%
EBITDA margin
-3019.2%
EBIT margin
-3176.6%
Net margin
-4477.1%
FCF margin
-2865.9%
-103.3%
Return on equity
-65.2%
Return on assets
-52.0%
Return on invested capital
0.01x
Asset turnover
-$67.9M
Cash from operations
$7.81
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026